RETRACTABLE TECHNOLOGIES INC

Retractable Technologies, Inc. (NYSE American: RVP) operates as a manufacturer and marketer of safety medical products, primarily syringes and needles designed to protect healthcare workers and patients from needlestick injuries and cross-contamination. The company's website is www.retractable.com.

The company's dominant revenue-generating products are injection devices marketed under the VanishPoint®, Patient Safe®, and EasyPoint® brand names. Syringes comprised 65.1% of revenues, while EasyPoint® products accounted for 31.2% of sales, with other products including IV safety catheters and blood collection devices representing the remainder. Most products incorporate an automated needle retraction safety feature. The VanishPoint® 1mL syringes are specifically designed with low dead space, reducing wasted medication and potentially allowing additional doses from medication vials.

Retractable Technologies maintains manufacturing facilities in Little Elm, Texas, where it owns 35 acres of property, and utilizes manufacturers in China. In 2025, approximately 37.4% of units were produced domestically, with 62.6% sourced from Chinese manufacturers. The company employs 201 people, with 195 full-time employees.

The company distributes products throughout the United States and internationally via general line and specialty distributors, with domestic sales representing 84.2% of revenues. Retractable Technologies holds significant intellectual property rights, including patents jointly owned with founder Thomas J. Shaw under an exclusive license agreement dating to 1995. The company maintains registered trademarks for VanishPoint®, EasyPoint®, Patient Safe®, and associated slogans.

The company received substantial government contracts during the COVID-19 pandemic and operates under a Technology Investment Agreement with the U.S. Department of Defense that funded an $81.0 million facilities expansion through June 30, 2030. This agreement requires maintenance of equipment, capacity availability, and government preference during public health emergencies.

Retractable Technologies competes primarily on healthcare worker and patient safety, product performance, and quality, competing against larger established companies including Embecta Corp. and Becton, Dickinson and Company.